MyLinh Duong, PhD

MyLinh has over 8 years of experience in the field of cell and gene therapy from her work on CAR-T and CAR-NK cells with Bellicum Pharma and NKILT Therapeutics. She produced numerous publications, and she was the key developer of dual-switch CAR-T cell and CAR-NK cell technology. MyLinh leads our lab as a principal scientist and has significantly contributed to the initial constructs developed by NKILT Therapeutics. She has a BS in biochemistry and cell biology from Rice University, completed her PhD training in cancer biology from The University of Texas Graduate School of Biomedical Sciences, and was a postdoctoral fellow at Baylor College of Medicine.